Impact of the 92-gene assay on cost of diagnosis of tumor type in metastatic cancer of uncertain origin.
Tanya G. Bentley
Research Funding - bioTheranostics
Brock Schroeder
Employment or Leadership Position - bioTheranostics
Stock Ownership - bioTheranostics
Catherine A. Schnabel
Employment or Leadership Position - bioTheranostics
Stock Ownership - bioTheranostics
Jesse Ortendahl
Research Funding - bioTheranostics
Wendy C. Hsiao
Research Funding - bioTheranostics
Mark G. Erlander
Employment or Leadership Position - bioTheranostics
Stock Ownership - bioTheranostics
Michael S. Broder
Research Funding - bioTheranostics